Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 30 04:00PM ET
55.99
Dollar change
-1.02
Percentage change
-1.79
%
IndexRUT P/E- EPS (ttm)-0.25 Insider Own1.02% Shs Outstand50.66M Perf Week-3.18%
Market Cap2.84B Forward P/E162.17 EPS next Y0.35 Insider Trans-4.43% Shs Float50.15M Perf Month9.33%
Income-12.00M PEG- EPS next Q0.06 Inst Own102.78% Short Float / Ratio4.31% / 3.89 Perf Quarter-2.29%
Sales342.56M P/S8.28 EPS this Y89.13% Inst Trans3.04% Short Interest2.16M Perf Half Y13.55%
Book/sh12.05 P/B4.65 EPS next Y348.17% ROA-1.86% Target Price68.57 Perf Year-13.40%
Cash/sh6.80 P/C8.23 EPS next 5Y- ROE-2.07% 52W Range47.59 - 71.99 Perf YTD-10.46%
Dividend- P/FCF- EPS past 5Y-14.51% ROI-1.96% 52W High-22.23% Beta0.48
Dividend %- Quick Ratio11.25 Sales past 5Y625.42% Gross Margin71.72% 52W Low17.65% ATR2.25
Employees610 Current Ratio13.36 Sales Q/Q32.27% Oper. Margin-3.15% RSI (14)52.46 Volatility3.57% 3.92%
OptionableYes Debt/Eq0.00 EPS Q/Q122.77% Profit Margin-3.50% Rel Volume1.67 Prev Close57.01
ShortableYes LT Debt/Eq0.00 EarningsOct 30 AMC Payout- Avg Volume555.17K Price55.99
Recom1.29 SMA201.77% SMA502.47% SMA2001.86% Volume910,811 Change-1.79%
Date Action Analyst Rating Change Price Target Change
Jul-19-23Initiated Robert W. Baird Outperform $69
Jul-13-23Initiated KeyBanc Capital Markets Overweight $70
May-23-23Initiated CL King Buy $75
Apr-14-23Initiated Mizuho Buy $75
Mar-24-23Upgrade Needham Hold → Buy $71
Oct-21-22Initiated RBC Capital Mkts Outperform $85
Oct-12-22Initiated Jefferies Hold $75
Oct-10-22Downgrade Needham Buy → Hold
Apr-06-22Initiated Wolfe Research Outperform $69
Mar-02-22Resumed BofA Securities Buy $70
Nov-20-23 09:55AM
Nov-06-23 12:00PM
Nov-01-23 06:00AM
Oct-31-23 09:27AM
Oct-30-23 05:55PM
05:40PM Loading…
05:40PM
04:28PM
04:01PM
Oct-26-23 10:02AM
Oct-23-23 10:00AM
Oct-16-23 10:23AM
Oct-14-23 01:15PM
Oct-11-23 11:42AM
Oct-02-23 06:00AM
Sep-22-23 11:47AM
11:47AM Loading…
Sep-11-23 11:47AM
Aug-25-23 06:00AM
Aug-21-23 06:00AM
Jul-28-23 12:46PM
Jul-27-23 05:25PM
04:18PM
04:01PM
Jun-29-23 06:00AM
May-31-23 10:27AM
May-25-23 09:28AM
May-16-23 02:45AM
May-08-23 09:06AM
May-01-23 05:15PM
04:07PM
04:01PM
06:00AM Loading…
Apr-25-23 06:00AM
Apr-24-23 06:00AM
Apr-17-23 03:54PM
Apr-10-23 06:00AM
Mar-29-23 06:00AM
Mar-07-23 06:00AM
Mar-04-23 07:39AM
Mar-01-23 05:25PM
04:01PM
Feb-25-23 02:14PM
Feb-22-23 10:00AM
Feb-08-23 04:30PM
Jan-31-23 06:00AM
Jan-19-23 06:43AM
Jan-12-23 09:19AM
07:21AM
Jan-11-23 06:00AM
Dec-23-22 12:58PM
Dec-22-22 09:03AM
Dec-21-22 06:00AM
Dec-19-22 09:40AM
Dec-13-22 12:40PM
06:00AM
Dec-02-22 09:40AM
07:10AM
Nov-18-22 06:00AM
Nov-16-22 11:06AM
09:40AM
Nov-07-22 12:52PM
Nov-01-22 12:35PM
Oct-31-22 05:15PM
04:01PM
09:40AM
Oct-24-22 10:00AM
Oct-13-22 09:40AM
Oct-09-22 10:20AM
Sep-26-22 09:40AM
Sep-12-22 09:15AM
Sep-08-22 06:00AM
Sep-07-22 09:40AM
Aug-22-22 09:40AM
Aug-18-22 06:00AM
Aug-17-22 06:00AM
Aug-08-22 12:00PM
Aug-05-22 04:34PM
Aug-04-22 09:40AM
Aug-02-22 11:13PM
04:11PM
Aug-01-22 05:15PM
04:01PM
Jul-19-22 09:40AM
Jul-15-22 07:24AM
Jul-11-22 06:00AM
Jun-24-22 09:40AM
Jun-15-22 08:18AM
May-31-22 06:00AM
May-05-22 05:45PM
04:01PM
May-02-22 08:19AM
Apr-28-22 03:02PM
Apr-26-22 06:00AM
Apr-19-22 06:00AM
Apr-14-22 04:01PM
Apr-04-22 06:00AM
Mar-23-22 09:28AM
Mar-07-22 04:01PM
Feb-24-22 06:20PM
04:01PM
Feb-23-22 05:25PM
Feb-17-22 03:02PM
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dearen Danny L.President & CFOSep 29Option Exercise0.0011,250031,452Oct 03 07:37 PM
Dearen Danny L.President & CFOSep 29Sale56.877,675436,49023,777Oct 03 07:37 PM
Ford Alfred J JrChief Commercial OfficerAug 15Sale62.3414,769920,67134,565Aug 17 07:47 PM
Ford Alfred J JrChief Commercial OfficerJul 28Sale62.011,50093,02149,334Aug 01 08:01 PM
Dearen Danny L.President & CFOMay 26Sale49.467,999395,6469,202May 31 08:01 PM
Dearen Danny L.President & CFOApr 21Option Exercise14.1913,208187,42237,201Apr 25 08:06 PM
Dearen Danny L.President & CFOApr 21Sale60.2120,0001,204,13717,201Apr 25 08:06 PM
Dearen Danny L.President & CFOApr 20Option Exercise14.192,00128,39425,994Apr 24 08:35 PM
Dearen Danny L.President & CFOApr 20Sale60.012,001120,07323,993Apr 24 08:35 PM
Dearen Danny L.President & CFOMar 31Option Exercise16.0015,000240,03138,993Apr 04 08:24 PM
Dearen Danny L.President & CFOMar 31Sale55.2715,000829,10323,993Apr 04 08:24 PM
Sama RindaChief Operating OfficerFeb 21Sale56.2719,9291,121,41555,854Feb 23 08:19 PM
Sama RindaChief Operating OfficerFeb 21Sale56.533,392191,750608Feb 23 08:19 PM
COHEN RAYMOND WChief Executive OfficerFeb 01Sale60.938,117494,578160,596Feb 02 08:06 PM
Sama RindaChief Operating OfficerFeb 01Sale60.935,075309,22575,783Feb 02 08:07 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerFeb 01Sale60.933,979242,44565,302Feb 02 08:06 PM
Ford Alfred J JrChief Commercial OfficerFeb 01Sale60.933,705225,75050,834Feb 02 08:07 PM
Dearen Danny L.President & CFOFeb 01Sale60.933,246197,78223,993Feb 02 08:06 PM
Noblett KarenChief Medical OfficerFeb 01Sale60.9393156,72742,215Feb 02 08:06 PM
Dearen Danny L.President & CFOJan 31Option Exercise0.0025,250037,750Feb 02 08:06 PM
Ford Alfred J JrChief Commercial OfficerJan 31Option Exercise0.0016,500060,773Feb 02 08:07 PM
Sama RindaChief Operating OfficerJan 31Option Exercise0.0030,875094,283Feb 02 08:07 PM
COHEN RAYMOND WChief Executive OfficerJan 31Option Exercise0.0061,9680191,617Feb 02 08:06 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 31Option Exercise0.0022,125076,851Feb 02 08:06 PM
Noblett KarenChief Medical OfficerJan 31Option Exercise0.0010,250046,849Feb 02 08:06 PM
COHEN RAYMOND WChief Executive OfficerJan 31Sale61.1522,9041,400,595168,713Feb 02 08:06 PM
Sama RindaChief Operating OfficerJan 31Sale61.1513,425820,93280,858Feb 02 08:07 PM
Dearen Danny L.President & CFOJan 31Sale61.1610,511642,82227,239Feb 02 08:06 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 31Sale61.147,570462,85469,281Feb 02 08:06 PM
Ford Alfred J JrChief Commercial OfficerJan 31Sale61.156,234381,23554,539Feb 02 08:07 PM
Noblett KarenChief Medical OfficerJan 31Sale61.153,703226,43743,146Feb 02 08:06 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 17Option Exercise17.4830,215528,05060,976Jan 19 08:07 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 17Sale67.3430,2152,034,53145,976Jan 19 08:07 PM
Ford Alfred J JrChief Commercial OfficerJan 13Option Exercise13.5236,015486,81772,788Jan 18 08:03 PM
COHEN RAYMOND WChief Executive OfficerJan 13Sale65.9440,7362,686,001108,899Jan 18 08:04 PM
Ford Alfred J JrChief Commercial OfficerJan 13Sale66.4036,0152,391,41536,773Jan 18 08:03 PM
Lopez EstebanDirectorDec 13Sale67.422,000134,8403,600Dec 15 08:12 PM